These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6375877)

  • 1. [Monocomponent insulins in the treatment of juvenile diabetes].
    Kopecký A; Vavrinec J; Kimlová I; Pospísilová D
    Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of semisynthetic human insulin.
    Rogala H; Lawecki J; Czyzyk A
    Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-insulin antibodies and their development in relation to therapy].
    Synek M
    Cesk Pediatr; 1987 Oct; 42(10):614-6. PubMed ID: 3322582
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum levels of insulin-binding antibodies in diabetic children treated with monocomponent insulin].
    Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A
    Pol Tyg Lek; 1974 Apr; 29(16):641-3. PubMed ID: 4827230
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of semisynthetic human insulin in juvenile insulin-dependent diabetes mellitus].
    Sacchetti C; Foco A; David O; Balboni R; Gargano P; Cerutti F; Baratono S
    Minerva Pediatr; 1989 May; 41(5):221-2. PubMed ID: 2677642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission.
    Ludvigsson J
    Diabetologia; 1984 Feb; 26(2):138-41. PubMed ID: 6370760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of monocomponent human and porcine insulin in non-insulin dependent diabetes mellitus.
    Lam HC; Tang KT; Wang JT; Liu YF; Wang LM; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Mar; 41(3):217-22. PubMed ID: 3052740
    [No Abstract]   [Full Text] [Related]  

  • 11. Extreme insulin resistance: a consequence of insulin switching?
    Keenan WF; Abgott MA
    J Fam Pract; 1988 Dec; 27(6):635-6. PubMed ID: 3058859
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of juvenile diabetics with highly purified insulin preparations--effect on the formation insulin antibodies and metabolic compensation].
    Michalková D; Bircák J; Cársky J; Kolár J; Sílesová J; Zmeková-Jancová E
    Cesk Pediatr; 1985 Apr; 40(4):219-23. PubMed ID: 3893762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of semisynthetic human insulin and porcine insulin in diabetic patients with or without circulating anti-insulin antibodies].
    Vandeleene B; Ketelslegers JM; Lambert AE
    Acta Clin Belg; 1983; 38(6):360-8. PubMed ID: 6369853
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin antibodies in the serum of diabetic children treated from the diagnosis of the disease with highly purified insulins.
    Akerblom HK; Mäkelä AL
    Acta Paediatr Scand Suppl; 1977; (270):69-79. PubMed ID: 98959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies against therapeutic animal insulins and homologous proteins in the course of diabetes in children and adolescents].
    Karczewska K
    Med Dosw Mikrobiol; 1974; 26(4):317-24. PubMed ID: 4475335
    [No Abstract]   [Full Text] [Related]  

  • 16. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children.
    Bistritzer T; Sack J; Theodor R; Weissglass L; Ben-Bassat I; Lahav M
    Horm Res; 1984; 20(3):178-85. PubMed ID: 6386647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-insulin antibodies in diabetes mellitus in children].
    Martynova MI; Ermolin GA; Smirnov VV; Galybin AA; Marchenko LF
    Pediatriia; 1988; (4):8-11. PubMed ID: 3060831
    [No Abstract]   [Full Text] [Related]  

  • 19. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
    Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
    Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of human insulin in cases of insulin allergy].
    Gerö L; Kerényi Z; Bányai Z; Tamás G
    Orv Hetil; 1989 May; 130(22):1159-62. PubMed ID: 2668841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.